Under construction – not a live service
Sign in
Taking people in SpainNo phase

New Device Tested During Colonoscopy to Help Find Bowel Polyps

Tests a microwave device during colonoscopy in 50 adults to find bowel polyps.

Plain-language title generated from the registry record
Registry title: Performance and Safety of MiWEndo-assisted Colonoscopy (MiWEndo II)

Key facts

Where
Barcelona, SpainSee the site

AI summary: who the study is looking for

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults sent for a screening or surveillance colonoscopy because they have a high risk of colorectal polyps or cancer. A new microwave device is used during the colonoscopy.

Age
Older than 18 years
Sex
All sexes can join
Disease stage
High risk of colorectal cancer or polyps, for example a positive faecal occult blood test, earlier removed polyps under surveillance, hereditary polyposis syndromes, Lynch Syndrome or familial cancer

Main reasons for not taking part

  • High risk of major complications such as perforation or bleeding
  • Suspected or proven lower gastrointestinal bleeding
  • Clotting problem that cannot be corrected, or anticoagulant/clopidogrel therapy during the procedure
  • Inadequate bowel cleansing
  • ASA-IV patients or urgent colonoscopy

Read by machine on 9 November 2026.

Where in Spain

  • Hospital ClinicBarcelona, SpainTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
MiWEndo Solutions S.L.
Trial code
NCT05988645
Record updated
8 October 2026
Original description
The study involves the planned use of a new microwave-based device during colonoscopy procedures in 50 patients to assess the performance and safety of its use for detection of colorectal polyps and lack of normal clinical practice modification. The device is a final design version, which has been previously tested in several preclinical studies (including phantom studies, an ex vivo study with human tissues, and an in vivo study with porcine model) and in a pilot study in humans (NCT05477836)Read full original descriptionShow less

Performance and Safety of MiWEndo-assisted Colonoscopy: MiWEndo II (Pivotal Study)

The study involves the planned use of a new microwave-based device during colonoscopy procedures in 50 patients to assess the performance and safety of its use for detection of colorectal polyps and lack of normal clinical practice modification. The device is a final design version, which has been previously tested in several preclinical studies (including phantom studies, an ex vivo study with human tissues, and an in vivo study with porcine model) and in a pilot study in humans (NCT05477836)

Inclusion: Patients older than 18-year-old referred for a screening or surveillance colonoscopy because of a high-risk condition of developing colorectal cancer or having colorectal polyps as fecal occult blood test (FOBT) positive, previously resected polyps under surveillance, hereditary polyposis syndromes, Lynch Syndrome or familial cancer; These criteria will ensure the probability of finding polyps during the explorations; All the patients will give written informed consent.

Exclusion: Patients at a high risk of having major complications as perforation or hemorrhage, suspected or proven lower gastrointestinal bleeding, non-correctable coagulopathy or anticoagulant/clopidogrel therapy during procedure, inadequate bowel cleansing; ASA-IV patients; Urgent colonoscopy.

ClinicalTrials.gov NCT05988645